Bepo

Long-acting injectable formulation technologies: Challenges and opportunities for the delivery of fragile molecules

By Medincell28/07/2022No Comments

Long-acting injectable formulation technologies: Challenges and opportunities for the delivery of fragile molecules

28/07/2022

Previous PostProof-of-concept study for a long-acting formulation of ivermectin injected in cattle as a complementary malaria vector control tool
Next PostIntra-articular delivery of full-length antibodies through the use of an in situ forming depot

Nos engagements

Signalement éthique

Mentions légales

Protection des données

Better medicine for all

Website by ScreenUp